British Columbia Investment Management Corp Alnylam Pharmaceuticals, Inc. Transaction History
British Columbia Investment Management Corp
- $15.9 Billion
- Q4 2024
A detailed history of British Columbia Investment Management Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 24,582 shares of ALNY stock, worth $5.83 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
24,582
Previous 21,108
16.46%
Holding current value
$5.83 Million
Previous $5.81 Million
0.38%
% of portfolio
0.04%
Previous 0.04%
Shares
29 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$3.94 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.02 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.26 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.65 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.04 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...